| Medical and Health Sciences | Lifetime | 465 | DE 13 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 173 | DE 8 | 99.97 |
| Environmental Science and Ecology | 2021-2025 | 780 | DE 23 | 99.24 |
| Speech and Hearing | Lifetime | 6 | DE 1 | 99.78 |
| Medical Physiology | Lifetime | 119 | DE 6 | 99.82 |
| Cardiology and Cardiovascular Medicine | Lifetime | 211 | DE 9 | 99.73 |
| Health, Toxicology and Mutagenesis | Lifetime | 238 | DE 9 | 99.05 |
| Biochemistry | Lifetime | 379 | DE 39 | 94.66 |
| Internal Medicine | Lifetime | 269 | DE 10 | 93.85 |
| Ophthalmology | Lifetime | 813 | DE 35 | 76.60 |
| Speech and Hearing | 2021-2025 | 2 | DE 1 | 99.92 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 25 | DE 1 | 99.74 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 165 | DE 6 | 99.14 |
| Surgery | 2021-2025 | 848 | DE 39 | 92.42 |
| Medical Physiology | 2021-2025 | 596 | DE 27 | 90.81 |
| Internal Medicine | 2021-2025 | 74 | DE 4 | 91.32 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 813 | DE 41 | 89.30 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 722 | DE 47 | 83.15 |
| Immunology | 2021-2025 | 843 | DE 60 | 70.44 |
| Nitric Oxide and Endothelin Effects | Lifetime | 8 | DE 1 | 99.91 |
| Noise Effects and Management | Lifetime | 13 | DE 2 | 99.63 |
| Climate Change and Health Impacts | Lifetime | 34 | DE 4 | 99.61 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 32 | DE 4 | 99.67 |
| Renin-Angiotensin System Studies | Lifetime | 44 | DE 9 | 99.23 |
| Air Quality and Health Impacts | Lifetime | 195 | DE 9 | 99.46 |
| Cardiovascular Disease and Adiposity | Lifetime | 176 | DE 8 | 99.02 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 102 | DE 15 | 98.77 |
| Cardiac Imaging and Diagnostics | Lifetime | 470 | DE 33 | 99.23 |
| Acute Myocardial Infarction Research | Lifetime | 265 | DE 17 | 99.10 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 467 | DE 29 | 98.67 |
| Cardiovascular Health and Disease Prevention | Lifetime | 268 | DE 7 | 98.60 |
| Vehicle Noise and Vibration Control | Lifetime | 66 | DE 5 | 97.88 |
| Cardiac Ischemia and Reperfusion | Lifetime | 262 | DE 21 | 98.17 |
| Blood Pressure and Hypertension Studies | Lifetime | 472 | DE 12 | 98.64 |
| Coronary Interventions and Diagnostics | Lifetime | 502 | DE 39 | 98.56 |
| Heart Failure Treatment and Management | Lifetime | 504 | DE 29 | 98.15 |
| Electron Spin Resonance Studies | Lifetime | 331 | DE 27 | 97.01 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 568 | DE 35 | 97.51 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 72 | DE 11 | 95.95 |
| Cardiac Health and Mental Health | Lifetime | 538 | DE 21 | 96.60 |
| Antioxidant Activity and Oxidative Stress | Lifetime | 779 | DE 41 | 95.86 |
| Peripheral Artery Disease Management | Lifetime | 903 | DE 58 | 95.68 |
| Vitamin C and Antioxidants Research | Lifetime | 445 | DE 16 | 94.54 |
| Phonocardiography and Auscultation Techniques | Lifetime | 236 | DE 3 | 91.99 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 481 | DE 28 | 91.55 |
| Health, Environment, Cognitive Aging | Lifetime | 868 | DE 20 | 90.65 |
| Heart rate and cardiovascular health | Lifetime | 166 | DE 13 | 89.70 |
| Redox biology and oxidative stress | Lifetime | 595 | DE 50 | 90.07 |
| COVID-19 impact on air quality | Lifetime | 615 | DE 9 | 73.96 |
| Noise Effects and Management | 2021-2025 | 1 | DE 1 | 99.86 |
| Air Quality and Health Impacts | 2021-2025 | 17 | DE 1 | 99.78 |
| Climate Change and Health Impacts | 2021-2025 | 13 | DE 1 | 99.64 |
| Vehicle Noise and Vibration Control | 2021-2025 | 12 | DE 1 | 97.04 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 21 | DE 5 | 94.69 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 156 | DE 5 | 93.81 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 136 | DE 6 | 94.61 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 342 | DE 31 | 96.28 |
| Acute Myocardial Infarction Research | 2021-2025 | 350 | DE 19 | 95.62 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 37 | DE 7 | 92.02 |
| Phonocardiography and Auscultation Techniques | 2021-2025 | 55 | DE 2 | 90.11 |
| Peripheral Artery Disease Management | 2021-2025 | 486 | DE 34 | 89.64 |
| Cardiac Health and Mental Health | 2021-2025 | 488 | DE 13 | 87.98 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 829 | DE 43 | 84.46 |
| Health, Environment, Cognitive Aging | 2021-2025 | 595 | DE 16 | 83.18 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 226 | DE 18 | 79.60 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 488 | DE 31 | 77.58 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 437 | DE 5 | 58.86 |
| Renin-Angiotensin System Studies | 2021-2025 | 439 | DE 34 | 52.99 |
| Signaling Pathways in Disease | 2021-2025 | 821 | DE 63 | 49.92 |
| Redox biology and oxidative stress | 2021-2025 | 683 | DE 52 | 39.02 |
